Illustrative image – not actual.Reliance Life Sciences is planning to invest around Rs.1,000 crore for setting up four state-of-the-art facilities to manufacture generic drugs, discover molecules for new drugs and take contracts for manufacturing drugs for other pharmaceutical companies in India.
The foray into drug manufacturing will start with the setting up of four FDA-compliant facilities near Mumbai and Pune. Work on the first facility will begin by March 2007 and commercial production is expected by August or September 2007. The group currently owns and runs HN Hospital in Mumbai.
Also See:
Reliance Life Sciences plans Rs.1,500 crore manufacturing facility (02-Nov-05)
